𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum Epstein–Barr virus (EBV) viral load can be a complementary sensitive test in primary Epstein–Barr virus infection

✍ Scribed by Mario Berth; Geert Vanheule; Christophe Depuydt; Ina Benoy

Book ID
116632004
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
126 KB
Volume
50
Category
Article
ISSN
1386-6532

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum epstein–barr virus DNA load in pri
Serum epstein–barr virus DNA load in primary epstein–barr virus infection
✍ Claudia C. Bauer; Stephan W. Aberle; Theresia Popow-Kraupp; Magdalena Kapitan; H 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract Specific viral laboratory diagnosis of primary Epstein–Barr Virus (EBV) infection is usually based on antibody‐detection assays. During acute, lytic phase of infection, viral DNA can also be detected in serum. In the present study, the diagnostic utility of EBV DNA detection and quantit

Epstein–Barr virus can infect rabbits by
Epstein–Barr virus can infect rabbits by the intranasal or peroral route: An animal model for natural primary EBV infection in humans
✍ Keisuke Okuno; Kazuaki Takashima; Kyosuke Kanai; Makoto Ohashi; Ryosuke Hyuga; H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

## Abstract Epstein–Barr virus (EBV) is spread universally in humans, and it causes infectious mononucleosis and sometimes induces serious EBV‐associated disease. The detailed mechanism of primary infection in humans has remained unclear, because it is difficult to examine the dynamics of EBV in vi

Laboratory markers of tumor burden in na
Laboratory markers of tumor burden in nasopharyngeal carcinoma: A comparison of viral load and serologic tests for Epstein-Barr virus
✍ Hongxin Fan; John Nicholls; Daniel Chua; K.H. Chan; Jonathan Sham; Shuko Lee; Ma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 242 KB

## Abstract Epstein‐Barr virus (EBV) is present within the tumor cells of most cases of nasopharyngeal carcinoma (NPC). Recent studies suggest that tumor burden is proportional to the level of EBV DNA in blood and that rapid blood testing can be used to guide therapeutic intervention. The relative